TMC the metals company charts risky path to 2027

TMC the metals company Inc. ((TMC)) has held its Q1 earnings call. Read on for the main highlights of the call.

TMC the metals company Inc. struck a cautiously optimistic tone on its latest earnings call, pointing to major milestones in regulation, engineering and financing that push its deep-sea nodule project closer to commercialization. Management also acknowledged mounting costs, continued losses and regulatory uncertainty that could still challenge execution and timelines.

Production Deal with Allseas Anchors First Commercial System

TMC detailed a binding production agreement signed with Allseas on May 11 to complete, commission and operate its first commercial polymetallic nodule collection system. Allseas will fund a significant share of preproduction costs, to be repaid from future output, and plans to start integration and commissioning of the system in late 2027.

NOAA Compliance Moves U.S. Permit Process Forward

The company reported that NOAA has found TMC’s consolidated application in full compliance with the Deep Seabed Hard Mineral Resources Act. This triggers posting to the Federal Register and formal public comment and environmental review steps, and management currently expects a commercial recovery permit around Q1 2027.

Engineering Program Advances Toward Late‑2027 Commissioning

Concept and basic engineering for critical offshore packages, including riser, nodule recovery, umbilical and vessel integration systems, are now substantially complete. TMC plans to move into procurement and subcontracting next, targeting integration and commissioning in late 2027 with a design intended for continuous and scalable nodule collection.

Economic Studies Highlight Large-Scale Project Value

Management emphasized updated economic studies showing a pre‑feasibility study NPV of $5.5B and an initial assessment NPV of $18.1B, for a combined value of about $23.6B. Across the life of the projects, the studies point to roughly $369B in undiscounted revenue, over $200B in EBITDA and first‑quartile positioning on the global nickel cost curve.

Liquidity Strengthens as Cash Burn Narrows Sharply

TMC ended March 31, 2026 with about $164M in liquidity, including $44M of undrawn credit capacity, providing a cushion as development spending ramps. Net cash used in operating activities fell to roughly $0.6M in Q1 2026 from $9.3M a year earlier, with free cash flow improving to negative $0.6M from negative $9.4M.

Onshore Strategy Centers on Brownsville and Mariana Deal

Onshore, TMC holds an exclusive right to negotiate for about 1,466 acres at the Port of Brownsville, where it is running a pre‑feasibility study on a potential 12 Mtpa industrial park. A strategic partnership with Mariana Minerals aims to speed feasibility work while deploying automation, advanced process controls and AI to optimize processing and refining.

TMCR Listing Unlocks Additional Balance Sheet Optionality

The Metals Royalty Company, or TMCR, has begun trading on Nasdaq with a market capitalization of roughly $0.75B. TMC’s 25% stake implies a near‑$200M look‑through value, and the company retains repurchase rights on certain royalty interests as TMCR adds new assets such as Mesabi Metallics.

Persistent Net Losses Underscore Long Build‑Out Cycle

Despite milestones, TMC remains firmly in the red, posting a net loss of $20.6M in Q1 2026, essentially flat versus the prior year. Loss per share improved modestly from $0.06 to $0.05, reflecting share count effects, but commercial revenues are still several years away.

Operating Costs Surge on Compensation and Study Refresh

Operating expenses climbed sharply, with exploration and evaluation costs rising 40% year over year to $13.3M and G&A more than doubling to $20.7M. Management tied the spike mainly to share‑based compensation and retention grants, as well as higher costs linked to refreshing the pre‑feasibility study.

Payables to Allseas Flag Dilution Risk

Accounts payable and accrued liabilities totaled $53.9M, including $32.1M owed to Allseas for project work to date. Most of this balance is slated to be settled via issuance of TMC shares, raising dilution concerns, while excluding the Allseas and $9M tax items would leave about $13M of underlying payables.

Regulatory Timeline Still Exposed to Slippage

While the NOAA compliance determination is a major step, management stressed that several public comment and environmental impact stages remain, with no binding statutory deadlines. That leaves real timing risk around the targeted Q1 2027 permit date, which could shift if reviews take longer than anticipated.

Heavy Reliance on External Capital and Policy Support

Development of the Brownsville site is contingent on securing government backing, and TMC has not committed capital to full build‑out yet. The company remains dependent on its cash reserves, undrawn credit facilities and partner funding, with upcoming warrant expirations adding another layer of financing uncertainty.

Complex Offshore Operations Pose Execution Challenges

Management acknowledged the technical demands of synchronizing multiple vessels, dynamic positioning and offshore transfer logistics in deep water. Many of the more radical cost‑cutting ideas, including autonomy, nuclear‑powered vessels and larger collector spreads, are long‑term options that may not meaningfully reduce early operating costs.

Guidance Points to 2027 as Pivotal Commercialization Year

Looking ahead, TMC reiterated its roadmap with a commercial recovery permit expected around Q1 2027 and first‑module integration and commissioning targeted in Q4 2027, followed by initial production. The company plans to share capex with Allseas while advancing a project slate that, on paper, carries NPVs above $20B and significant revenue potential if technical, regulatory and funding hurdles can be cleared.

TMC’s earnings call painted a picture of a company moving steadily toward commercialization of a potentially massive resource, backed by a key production partner and fresh economic validation. Investors will now weigh that upside against rising costs, dilution and regulatory overhangs, making execution over the next two years critical for the stock’s long‑term narrative.